Heterocyclic systems containing bridgehead nitrogen atom: Synthesis and biological activities of some substituted striazolo[3,4-b] [1,3,4]thiadiazoles by Gupta, Rajive et al.
Indian .Toumal of Chemistry
Vol. 37B, May 1998, pp. 498 - 501
Heterocyclic systems containing
bridgehead nitrogen atom: Synthesis and
biological activities of some substituted s-
triazolo[3 ,4-b] [1,3,4 ]thiadiazoles
Rajive Gupta", Satya Paul, Avinash K Gupta
& P L Kachroo
Department of Chemistry




Regional Research Laboratory, Jammu 180 00 I
Received 23 September 1996: accepted (revised)
J4 October J997
Various 3-alky I/ary 1-6-(2-ch loro-2-substituted-phenyl
ethenyl)-5, 6-dihydro-s-triazolo [3,4-b][ J ,3,4]-thiadia-
zoJes 3 have been synthesised by the condensation of 3-
substituted-4-amino-5-mercapto-I,2,4-triazoles 1 with
various substituted p-chlorocinnamaldehydes 2 in
benzene containing a catalytic quantity of p- TsOH using
Dean-Stark apparatus, Structures of thiadiazoles 3 have
been established on the basis of analytical and spectral
data, The thiadiazoles 3 have been assessed for
antiinflammatory, antibacterial and antifungal activities,
Substituted 1,2,4-triazoles and the N-bridged
heterocycles derived from them amongst the
various heterocycles that have received
considerable attention during the last two decades
as potential bioactive agents"!", In continuation of
our work on the synthesis of biologically active
nitrogen and sulphur containing heterocycles'Y'",
we have synthesised triazolo-thiadiazole system
which may be viewed as a cyclic analogue of two
very important components, i.e. thiosemi-
carbazidel5 and biguanide", which often display
diverse biological activities, It has been reported"
that some of their derivatives exhibit pronounced
analgesic, antiasthmatic, diuretic, antihyper-
tensive, antibacterial, antifungal, antiinflamma-
tory, antitubercular and antiviral activities.
















R N 5 CI,
HN~\ /' RH -
3
3a R' ~ 4'· OMeC6H4, R ~ CI
b R' ~. CH2C6H5, R ~ CI
c R' ~ 2'· CH3C6H4, R ~ CI
d R' ~ CH3, R~CI
e: R' ~ C2H5, R ~ CI
f; R' ~ C 3H7, R ~ CI
g; R' ~ 4', OMeC6H4, R ~ OMc
h; R' ~. CH 2C6H5, R ~ OMe
i ; R' ~ 2'· CH 3C6H4, R ~ OMe
3 i : R' ~ CH3 ,R = OMe
k ; R' = C2H5 , R = OMe
I; R' ~ C3H7 ' R ~ OMe
rn R' ~ 4', OMeC;iH4 ,R ~ Br
n ; R' ~ CH2C6H5 ,R ~ Or
0: R' = 2' - CH3CGH4 ,R ~ Br
P: R' ~ CHl ,R r- Br
q : R' = C2HS ' n " Br
r; R' ~ C 31-17,H = Or
herein the synthesis of 3-alkyl/aryl-6- (2-chloro-2-
substituted-pheny I ethenyl )-5 ,6-d ihydro-s-triazolo-
[3,4-b] [1,3,4 [thiadiazoles 3 by the condensation of
3-alkyllaryl-4-amino-5-mercapto-I,2,4-triazoles 1
with various substituted f3-chlorocinnamal-dehydes
2 in benzene containing catalytic quantity of P:
TsOH using Dean-Stark apparatus 18, Most of the
reactions of f3-chlorocinnamaldehydes have been
used for the synthesis of condensed heterocyclic
systems where vinylic chlorine atom has been
displaced, The present reaction involves the
condensation of CHO group only and retains the
vinylic chlorine atom in the resultant compounds 3,
to study the effect of this vinylic chlorine atom on
the biological activities.
The required 4 - amino-3-aryl-5-mercapto-I.2.4-
triazoles were synthesised following the method of
Reid and Heindell,! and 3-alkyl-4-am ino-5-
mercapto-I, 2, -l-triazoles were synthe-sised from
thiocarbohydrazides by cyclisation in appropriate
aliphatic acids20, The substituted [1-
chlorocinnama Idehydes were prepared b)
Vilsmeyer-Haack reaction" of substituted
acetophenones.
The structural assignments of 3 are based on IR
and IH NMR data. The IR spectra of 3a-r showed
sharp bands near 1600 and 3200-3400 ern" due to
C=N and NH group. The bands that appeared at
3210, 3150 (NH2), 1130 ern" (C=S) and 1610 em"
(C=O), respectively for the starting triazoles 1and
J3-chlorocinnamaldehydes 2 were absent in the
newly formed compounds 3a-r. The IH NMR
spectra of 3a-r exhibited broad singlet peaks at 8
5.8-6.0 exchangeable with 020, due to NH proton,
whereas, 6-CH proton appeared as doublet at 8 6.4-
6.5. The -CH=C proton appeared as doublet buried
in the aromatic region.IHNMR spectra of3a-r also
showed the absence of peaks at 8 5.5-5.6 due to
NH2 protons present in triazoles. A broad signal of
one proton intensity at 8 12.8-13.1 attributed to SH
proton (exchangeable with 020)was also absent in
their IHNMR spectra.
Antiinflammatory activity
The compounds were tested for their
antiinflammatory activity by acute carrageenam-
induced Oedema test model in rats22 and exhibited
mild to moderate activity ranging from 9.63 to
39.21 % taking phenylbutazone as standard which
showed 58% inhibition (cf. Table I).
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Antibacterial and antifungal activities
The antibacterial activity of 3a-r was
determined in vitro using paper disc method
against two pathogenic microorganisms viz., E.
eoli (Gram-negative and S. aureus (Gram-positive)
at 200 ug/ml, and I00 ug/ml. concentrations
respectively, in the nutrient agar media. The
compounds 3a-r were not significantly active
towards these bacteria.
Similarly, the antifungal screening of 3a-r was
carried out in vitro by paper disc method against
two fungi viz., A. niger and c. a/bieans and they
did not show significant antifungal activity as well.
Experimental Section
All melting points were taken on Buchi melting
point apparatus and are uncorrected. Homogeniety
of the compounds was routinely checked on silica
gel-G TLC plates using benzene-ethyl acetate (4: 1)
as eluant. IR spectra (vrnax in cm') were recorded
on Shimadzu - 435 Spectrophotometer using KBr
disc and IH NMR spectra in COCh/COCh
+OMSO-d6 (chemical shifts in 8, ppm) on Varian
T-60A and EM-390 spectrometers (60 MHz and 90
MHz) using TMS as internal standard.
6-[2-Chloro-2-( 4-chlorophenyl)ethenyl]-3- (4-
me-thoxyphenyl)-5,6-dihydro-s-triazolo[3,4-
Table !-Characterisation data and antiinflammatory activity of 3a-r
Compd Yield rn.p. Mo\.formula Found (Calc.) (%) '/iNMR ( COCI,/COCI, + OMSO~,)8 . ppm Antiinflammatory activity
(%) \9(: C H N ( % Inhibition)
38 59 220-21 ClIH,.CI,N.OS 53.37 3.41 13.79 3.9 (s, 3H, -OCH3) , 5.9 (bs , 1H . NH ), 31.42
(53.33 3.45 13.82) 6.5 (d,lH ,CH). 6.9 - 8.0 (m,8H, Ar-H
and d buried 1H , -CH = C)
3b 58 166-67 ClIH,.CI2N.S 55.50 3.64 14.36 4.2 (s,2H,Ar-Ct!z)' 5.7 (bs,lH,NH ), 12.0
(55.52 3.59 14.39) 6.4(d,lH.CH), 7.0 - 8.0 (m. 9H, Ar-H
and d buried 1H, - CH = C)
3c 65 233 ClIH,.CI2N.S 55.49 3.57 14.37 2.3 (s,3H. -CH.) ,5.9(bs,lH,NH), 38.57
(55.52 3.59 14.39) 6.5 (d,lH,CH):6.9 - 8.1(m. 8H, Ar·H
and d buried 1H. ·CH =C)
3d 69 226 - 29 C'2H,.CI2N.S 45.97 3.15 17.93 2.3(s,3H, ·CH.), 5.8( bs.1H,NH ), 9.63
(46.00 3.19 17.89) 6.5 (d,lH,CH), 7.3·7.8 (m,4H, Ar-H
and d burie.d 1H, ·CH =C)
3. 65 163 C,.H12CI2N.S 47.69 3.64 17.07 1.3 ( t.3H, .CH2-ICH, ), 2.8 (q, 2H,-CtlaCH.), 26.0
(4770 3.66 17.12) 5.9(bs, 1H,NH), 6.4(d,1H,CH), 7.5· B.O
(m, 4H, Ar·H and d buried 1H, -CH =C)
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Table I---Characterisation data and antiinflammatory activity of3a-r
Compd Yield m.p Mol. formula Found (Calc.) (%) IHNMR(CDCliCDCI)+DMS Antiinfl0c. O-d6) ammator
y
activity
3f 60 138 C,.H,.CI2N.S 49.25 4.09 16.39 1.1 (I ,3H,-CH2CH,,<;H.') ,1.9(m,2H,-CH.CH.,cH.), 15.66
(49.26 4.10 16.42) 2.8(t,2H, - CH!CH2CH.), 5.9(bs,1 H,NH),
6.4(d, 1H,CH),7.5 - 8.0 (m,4H,Ar-H and
d buried 1H , -CH=C)
3g 62 185-86 C,. H17CIN.02S 56.90 4.21 13.96 3.9 (s,6H,2x-OCH.), 5.9( bS,1 H,NH ), 31.42
(56.92 4.24 13.98) 6.4(d,1H,CH), 6.9'- 8.0(m, 8H, Ar-H and
d buried 1H,-CH=C)
3h 65 169 C,.H17CIN.OS 59.27 4.38 14.63 3.8(s,3H,-OCH.), 4.3( s,2H,Ar-C!:!.2)' 31.42
(59.29 4.42 14.56) 5.9(bs, 1H,NH),64(d,1 H,CH),6.8-8.0
(m, 9H. Ar-H end d buried 1H,-CH=C)
31 60 210-11 C,.H17CIN.OS 59.25 4.37 14.59 2.3(s,3H,-CH.1.3.9(a,3H,-OCH. ), 10.0
(59·lQ 4.42 14.56) 5.8(bs.1H,NH),6.3(d,1 H,CH),6.8-8.0
(rn, 8H, Ar-H and d buried 1H,-CH=C)
3J 65 214 C" H" CIN. OS 50.61 4.17 18.14 2.2(s.3H.-CH.). 39(s.3H,-OCH.), 39.21
(5056 4.21 18.15) 5.9( bs.1H.NH) . 6.5(d.1 H,CH),6. 7-8.0
(rn, 4H. Ar-H and d buried 1H. -CH=C)
3k 62 192-93 C,.H •• CIN.OS 52.05 4.61 17.38 1.3(t,3H.-CH2CI:f.1. 2.9( q. 2H.-CH,CH.), 22.4
(5209 4.65 17.36) 3.9(s.3H.-OCH. ).5.9(bs.1H.NH).6.4
(d,1 H.CH) . 6.8-8.0 (rn, 4H. Ar-H and d buried
1H, -CH=C)
31 50 121 C,.H17CIN.OS 53.46 5.01 - 16.68 1.1(t.3H.-CH2CH2 CH. ),2.0(m.2H.-CHJCH.CH.). 33.73
(5349 5.05 1664) 2. 9(t,2H. - CH,CH2CH. ).3. 9(s.3H, -OCH.). 5. 8
(bs. 1H.NH),6.4(d.1 H, CH),6.8-8.0(m, 4H, Ar-H
and d buried 1H. -CH=C)
3m 75 240 C"H,.BrCIN.OS 48.01 3.08 12.47 3.9(s.3H,-OCH. ),5.9(bs.1H.NH),6.5 (d,1 H,CHl. 18.29
(48.05 3.11 12.45) 6.9-8.1 (m, 8H, Ar-H and buried IH,-CH=C)
3" 70 154-55 C"H,.BrCIN.S 49.80 3.20 12.95 4.3(s,2H,Ar-CH, ), 5.9(bs,1 H,NH),6.4 11.72
(49.82 3.22 12.91) (d,1H,CH),7.0-8.0 (m, 8H, Ar-H and d buried
1H,-CH=C)
30 68 228-29 C"H,.BrCIN.S 49.80 3.24 12.90 2.3(s,3H,-CH, ),·5.9(bs, 1H.NH1.6.5 (d, 1H,CH), 37.5
(49.82 3.22 12.91 ) 70-8.1 (m, 8H, Ar-H and d buried 1H,-CI:I=C)
3p 84 219 C12H,.BrCIN.S 40.25 2.76 15.65 2.2(s,3H,-CH. ),5.9(bs, 1H,NH),6.5 22.6
(40.27 2.79 15.66) (d,1H,CH),7.4-8.0(m, 4H, Ar-H and
d buried 1H.-CH=C)
3q 80 186-87 C"H12BrCIN.S 42.03 3.20 15.04 1.3 (t,3H,-CH2Cti.). 2.9 (q,2H,-Cti.CH.), 12.0
(41.99 3.23 15.07) 5.9(bs,1H,NH), 6.4(d,1H,CHl. 7.6-8.0
(m, 4H, Ar-H and d buried 1H,-CH=C)
3r 72 143 C,.H,.BrCIN.S 43.52 3.60 14.55 1.1 (t,3H,-CH2CH2C!;!,), 1.9(m,2H,-CH, CH,CH.), 34.3
(43.57 3.63 14.52) 2.9(t,2H,-CH,CH2CH.1.5.9(bs, 1H,NH),
6.4 (d,1H,CH1.7.4-8.0(m,4H, Ar-H and
d buried 1H.-CH=C)
NOTES 501
b][l,3,-4]thiadiazole 3a : General procedure. An 9 Prasad A R, Rama Lingam T, Rao A B, Diwan P V &
equimolar mixture of 4-amino-5-mercapto-3- (4- SatturPB,EurJMedChern, 24, 1989, 199.
methoxyphenylj-s-triazole (I.llg, 0.005 mole), p- 10 Ewiss N F, Bahajaj A A & Elsherbini, J Heterocycl Chern,
chloro-Bcchlorocinnamaldehyde (1.0 g, 0.005 23,1986, 1451.
mole) p-TsOH (20 mg) in dry benzene (75 mL) 11 Gupta R, Paul S, Sharma M, Sudan S, Somal P & Kachroo
, . . ~ P L, Indian J Chem, 32B 1993 1187.was heated under reflux for 10 hr usrng Dean-Stark ' ,
device for the separation of evolved water. The 12 Gupta R, Sharma M, Paul S, Sudan S & Kachroo P L, J
I . d d h'd d Indian Chern Soc, 70, 1993,649.so vent was remove an t e rest ue extracte
with chloroform (75mL). The organic layer was 13 Gupta R, Sudan S, Mengi V & Kachroo P L, Indian J
h d . h (0 d' . d h d Chern, 35B, 1996,621.was e WIt water 2:>:<5mL), ne over an y. 14 Gupta R, Sudan S & Kachroo P L, Indian J Chern, 35B,
Na2S04 and the solvent evaporated. The residue 1996,718.
obtained, was crystallised from MeOH as white 15 Joshi K C & Giri S, J Indian Chern Soc, 40, 1963,42.
needles (1.19 g), m.p. 220-21 "C. .16 Hanglind J, Intern Cong Chernotherapy Proc, 3;:;;
C d 3b d . '1 I d Stuttgard, 1,1963,887.
ompoun s -r were prepare srrm ar y an 17 (a) Abd EI Samie Z K, AI-Ashmawi M I & Abd EI-Fattah
their characterization data are given in Table I. B, J Pharm Sci, 28, 1987,395.
(b) Kumar H, Patel V, Fernandes P S & Avyas K, Indian J
Chern, 29B, 1990, 135.
(c) Bano Q, Tiwari N & Nizammudin, Indian J Chern,
3IB, 1992,467.
(d) Abd EI Samie Z K, EI-Feky S A, Jaeda M I & Hassan
E, Zhonghua Xaoxue Zazhi, 43, 1991, 237; Chern Abstr,
115, 1991, 247678x.
(e) Zhang Z, Zhao L, Li, Ming Li Zhangming & Liao R,
Youji Hauxue, 14, 1994, 74; Chern Abstr, 121, 1994,
9267s.
18 Bicking J B, Book M G, Gragoe (Jr) E J, Diprado R M,
Gould N P, Holtz W J, Lee T J, Robb C M, Smith R L,
Springer J P & BlaineE H, J Med Chern, 26, 1983,342.
19 Reid J R & Heindel N D, J Heterocycl Chern, 13, 1976,
925.
20 Gakhar H K, Jain A & Gupta S B, J Indian Chern Soc, 59,
1982,900.
2 I Chakraborty A & Ray J K, Synth Commun, 25, 1995,
1869.
22 Winter C A, Risley E T & Nuss G W, Proc Soc Exptl Bioi
Med, 3,1962,544.
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